WELL Health Technologies (TSE:WELL) Shares Down 0.8% - Time to Sell?

Key Points

• WELL Health Technologies' shares declined by 0.8% to C$5.03, with a trading volume increase to approximately 993,214 shares.
• The company has a market cap of C$1.28 billion and reported a PE ratio of -10.48, indicating a potential valuation challenge.
• Insider Eva Fong sold 15,000 shares at an average price of C$4.75, reducing her holding in the company by 0.75%.

WELL Health Technologies Corp. (TSE:WELL - )'s share price fell 0.8% on Thursday . The stock traded as low as C$4.91 and last traded at C$5.03. 993,214 shares traded hands during trading, an increase of 4% from the average session volume of 954,786 shares. The stock had previously closed at C$5.07.

WELL Health Technologies Stock Performance

The company's 50-day moving average price is C$4.78 and its two-hundred day moving average price is C$4.44. The company has a debt-to-equity ratio of 46.79, a quick ratio of 1.02 and a current ratio of 1.14. The stock has a market cap of C$1.28 billion, a PE ratio of -10.48, a PEG ratio of -1.93 and a beta of 1.05.

Insider Buying and Selling at WELL Health Technologies

In other news, insider Eva Fong sold 15,000 shares of the firm's stock in a transaction on Friday, August 29th. The shares were sold at an average price of C$4.75, for a total transaction of C$71,250.00. Following the sale, the insider owned 1,973,819 shares in the company, valued at approximately C$9,375,640.25. This trade represents a 0.75% decrease in their position. Company insiders own 6.80% of the company's stock.

WELL Health Technologies Company Profile

WELL Health Technologies Corp is the owner and operator of a portfolio of Primary Hclinics delivering healthcare-related services It operates through below segments: clinical operations and allied health, Electronic medical record (EMR), Billing and revenue cycle management solutions, Digital apps, Cybersecurity, CRH, MyHealth, and corporate/shared services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.